LISATA THERAPEUTICS, INC. — Director's Dealing 2015

Jan 2, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2015-01-02

Reporting Person: BERNSTEIN DREW (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-01-02	Stock Option (Right to Buy)	$3.73	A	28000	Acquired	2025-01-01	Common stock, par value $0.001 per share (28000)	Direct

Footnotes

F1: On January 2, 2015 (the "Grant Date"), the Reporting Person was granted an option to purchase 28,000 shares of the Issuer's common stock of, subject to all of the terms and conditions of the Issuer's 2009 Amended & Restated Equity Compensation Plan and pursuant to the Issuer's Director Compensation Plan. This option was fully vested on the Grant Date.